Invention Grant
- Patent Title: Methods for administering angiotensin II
-
Application No.: US16604851Application Date: 2018-04-13
-
Publication No.: US11583568B2Publication Date: 2023-02-21
- Inventor: Lakhmir Chawla , George Tidmarsh , Steve Ching Tsung Chen
- Applicant: La Jolla Pharma, LLC
- Applicant Address: US CA San Diego
- Assignee: La Jolla Pharma, LLC
- Current Assignee: La Jolla Pharma, LLC
- Current Assignee Address: US CA San Diego
- Agency: Foley Hoag LLP
- Agent Lucas P. Watkins; Allison L. Gilder
- International Application: PCT/US2018/027593 WO 20180413
- International Announcement: WO2018/191678 WO 20181018
- Main IPC: A61K38/08
- IPC: A61K38/08 ; A61P9/12 ; A61K9/00 ; G01N33/68
Abstract:
The present disclosure relates to the use of angiotensin II, angiotensin III, or angiotensin IV in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.
Public/Granted literature
- US20200222493A1 METHODS FOR ADMINISTERING ANGIOTENSIN II Public/Granted day:2020-07-16
Information query
IPC分类:
